COYA vs RF
Coya Therapeutics, Inc. Common Stock (COYA) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
RF (RF) common stock.
Latest reported COYA revenue for 2024-12-31 was $3.6M. Net income was -$14.9M. Revenue was down 40.8% from 2023-12-31 to 2024-12-31. COYA currently screens at market cap $118.0M.
RF does not have a complete income-statement cache yet.
COYA currently screens at market cap $118.0M. RF currently screens at market cap $0.
Not investment advice. Open the COYA and RF stock pages for the full models.
Not investment advice.